Evidence map›Paper›PMID 25439845›Full record

ArticleFertility and sterility2015

Granulocyte colony-stimulating factor prevents loss of spermatogenesis after sterilizing busulfan chemotherapy.

Roberto Benavides-Garcia, Rose Joachim, Nancy A Pina, Kazadi N Mutoji, Matthew A Reilly, Brian P Hermann

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Fertility and sterility, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02783937 (Filgrastim for Treatment of Premature Ovarian Insufficiency), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02783937 phase4completednot on this mapstarted 2016, after this paper: background citation

Filgrastim for Treatment of Premature Ovarian Insufficiency: Randomized Clinical Trial

TypeinterventionalSponsorSouth Valley UniversityRan2016 to 2021Enrolled10ConditionsPremature Ovarian FailureArmsFilgrastim, Saline
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Approaches and Technologies in Male Fertility Preservation.International journal of molecular sciences · 2020
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Roberto Benavides-GarciaDepartment of Biology, University of Texas at San Antonio, San Antonio, Texas.
Rose JoachimDepartment of Biology, University of Texas at San Antonio, San Antonio, Texas.
Nancy A PinaDepartment of Biology, University of Texas at San Antonio, San Antonio, Texas.
Kazadi N MutojiDepartment of Biology, University of Texas at San Antonio, San Antonio, Texas.
Matthew A ReillyDepartment of Biomedical Engineering, University of Texas at San Antonio, San Antonio, Texas.
Brian P HermannDepartment of Biology, University of Texas at San Antonio, San Antonio, Texas. Electronic address: brian.hermann@utsa.edu.
The University of Texas at San Antonio · US

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lei Zheng · 1991 to 2026
$59.1M
INSTITUTE FOR INTEGRATION OF MEDICINE & SCIENCE: A PARTNERSHIP TO IMPROVE HEALTHUL1RR025767 · NCRR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A · 2008 to 2011
$23.8M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthKL2TR001118 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, DOUGHERTY, DONALD M · 2013 to 2017
$3.4M
Transcriptional regulatory networks in spermatogonial stem cellsR00HD062687 · NICHD · UNIVERSITY OF TEXAS SAN ANTONIO · PI HERMANN, BRIAN PETER · 2011 to 2013
$879k
Recruitment of New Stem Cell BiologistP30GM092334 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI MCCARREY, JOHN R · 2009 to 2010
$634k
G-CSF prevents male infertility after chemotherapy.R21HD078916 · NICHD · UNIVERSITY OF TEXAS SAN ANTONIO · PI HERMANN, BRIAN PETER · 2014 to 2015
$378k
Regulation of spermatogonial stem cell proliferation and differentiation by UTF1F32HD079235 · NICHD · UNIVERSITY OF TEXAS SAN ANTONIO · PI MUTOJI, KAZADI NADINE · 2014 to 2016
$173k
NCATS NIH HHS KL2 TR001118NCATS NIH HHS UL1 TR001120NCI NIH HHS P30 CA054174NCI NIH HHS P30CA54174NCRR NIH HHS UL1 RR025767NCRR NIH HHS UL1RR025767NICHD NIH HHS F32 HD079235NICHD NIH HHS R00 HD062687NICHD NIH HHS R00HD062687NICHD NIH HHS R21 HD078916NICHD NIH HHS R21HD078916NIGMS NIH HHS P30 GM092334
6 · The paper itself

Abstract

objectiveTo determine whether granulocyte colony-stimulating factor (G-CSF) could prevent loss of spermatogenesis induced by busulfan chemotherapy via protection of undifferentiated spermatogonia, which might serve as an adjuvant approach to preserving male fertility among cancer patients.

designLaboratory animal study.

settingUniversity. ANIMAL(S): Laboratory mice. INTERVENTION(S): Five-week-old mice were treated with a sterilizing busulfan dose and with 7 days of G-CSF or vehicle treatment and evaluated 10 weeks later (experiment 1) or 24 hours after treatment (experiment 2). MAIN OUTCOME MEASURE(S): Experiment 1: testis weights, epididymal sperm counts, testis histology. Experiment 2: PLZF immunofluorescent costaining with apoptotic markers. Molecular analysis of G-CSF receptor expression in undifferentiated spermatogonia. RESULT(S): Ten weeks after treatment, busulfan-treated mice that also received treatment with G-CSF exhibited significantly better recovery of spermatogenesis and epididymal sperm counts than animals receiving busulfan alone. G-CSF led to increased numbers of PLZF+ spermatogonia 24 hours after treatment that was not accompanied by changes in apoptosis. To address the cellular target of G-CSF, mRNA for the G-CSF receptor, Csf3r, was found in adult mouse testes and cultured THY1+ (undifferentiated) spermatogonia, and cell-surface localized CSF3R was observed on 3% of cultured THY1+ spermatogonia. CONCLUSION(S): These results demonstrate that G-CSF protects spermatogenesis from gonadotoxic insult (busulfan) in rodents, and this may occur via direct action on CSF3R+ undifferentiated spermatogonia. G-CSF treatment might be an effective adjuvant therapy to preserve male fertility in cancer patients receiving sterilizing treatments.

Indexed as

AnimalsAntineoplastic Agents, AlkylatingBusulfanDose-Response Relationship, DrugDrug InteractionsFertility PreservationGranulocyte Colony-Stimulating FactorInfertility, MaleMaleMiceMice, Inbred C57BLSpermatogenesisTreatment OutcomeAntineoplastic Agents, AlkylatingBusulfanGranulocyte Colony-Stimulating Factorcancer therapycytokinesfertility preservationinfertilitySpermatogonial stem cells

Identifiers

PMID25439845
PMCPMC4282609
OpenAlexW2085133395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.